Patent Portfolios and Competition Law: Some Reflections After the Recent RPSA Cases

In the pharmaceutical sector, firms often build patent portfolios in order to better protect their innovations, but also to strategically exploit the cluster to prevent entry by generic competition. In fact, once patent protection on the main invention expires, originator firms adopt a two-tiered s...

Full description

Saved in:
Bibliographic Details
Main Author: Emanuela Arezzo
Format: Article
Language:English
Published: Universidade Católica Editora 2023-06-01
Series:Market and Competition Law Review
Subjects:
Online Access:https://revistas.ucp.pt/index.php/mclawreview/article/view/12677
Tags: Add Tag
No Tags, Be the first to tag this record!